Diagnostic and management trends of giant cell arteritis: A physician survey

Journal of Rheumatology

Volumn 32, Issue 7, 2005, Pages 1283-1289

  Drehmer, Timothy J ^a,b   Khanna, Dinesh ^a,b   Markert, Ronald J ^a,b   Hawkins, Robert A ^a,b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

Biopsy; Corticosteroids; Giant cell arteritis; Physicians' practice patterns; Temporal artery

Indexed keywords

CORTICOSTEROID; CORTISONE; PREDNISONE;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC TEST; FAMILY MEDICINE; GIANT CELL ARTERITIS; HEALTH SURVEY; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOLOGY; SURGEON; UNITED STATES;

ADRENAL CORTEX HORMONES; BIOPSY; HEALTH CARE SURVEYS; HUMANS; PROFESSIONAL PRACTICE; RHEUMATOLOGY; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 22244477038     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am 1997;81:195-219.
2. Baldursson O, Steinsson K, Bjornsson J, Lie JT. Giant cell arteritis in Iceland: An epidemiologic and histologic analysis. Arthritis Rheum 1994;37:1007-12.
3. Scott KR. Temporal artery biopsy technique: a clinico-anatomical approach. Ophthalmol Surg 1991;22:519-25.
4. Buchbinder R, Detsky AS. Management of suspected giant cell arteritis: a decision analysis. J Rheumatol 1992;19:1220-8.
5. Asch DA, Patton JP, Hershey JC. Knowing for the sake of knowing: the value of prognostic information. Med Decis Making 1990;10:47-57.
6. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001;30:249-56.
7. Stone JH, Calabrese L, Hoffman GS, Pusey CD, Hunder GG, Hellmann DB. Vasculitis - a collection of pearls and myths. Rheum Dis Clin North Am 2001;27:677-728.
8. Elliot DL, Watts WJ, Reuler JB. Management of suspected temporal arteritis. A decision analysis. Med Decis Making 1983;3:63-8.
9. Allison MC, Gallagher PJ. Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis 1984;43:416-7.
10. Achkar AA, Lie JT, Hunder GG, O'Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994;120:987-92.
11. Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest 1997;99:2842-50.
12. Murgatroyd H, Milne A. Positive temporal artery biopsy in a patient on therapeutic doses of steroids for six years. Eye 2001;15:250-1.
13. Guevara RA, Newman NJ, Grossniklaus HE. Positive temporal artery biopsy six months after prednisone treatment. Arch Ophthalmol 1998;116:1252-3.
14. Evans JM, Batts KP, Hunder GG, et al. Persistent giant cell arteritis despite corticosteroid treatment. Mayo Clin Proc 1994;69:1060-1.
15. Fauchald P, Rygvold O, Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med 1972;77:845-52.
16. Ponge T, Barrier JH, Grolleau JY, Ponge A, Vlasak AM, Cottin S. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheumatol 1988;15:997-1000.
17. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123:285-96.
18. Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol 1999;128:211-5.
19. Kellner JL. Giant cell arteritis: Signs and symptoms. Ophthalmology 1982;89:1101-10.
20. Rosenfeld SI, Kosmorsky GS, Klingele TG, Burde RM, Cohn EM. Treatment of temporal arteritis with ocular involvement. Am J Med 1986;80:143-5.
21. Hayreh SS, Zimmerman B, Kardon RH, Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand 2002;80:355-67.
22. Cornblath WT, Eggenberger E. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone. Ophthalmology 1997;104:854-8.
23. Younge BR, Cook BE Jr, Bartley GB, Hodge DO, Hunder GG. Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc 2004;79:483-91.
24. Erratum in: Mayo Clin Proc 2004;79:709.
25. Mayo Clin Proc 1004;79:1341.
26. Chevalet P, Barrier JH, Pottier P, et al. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. J Rheumatol 2000;27:1484-91.
27. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998;125:521-6.
28. Hayreh SS. Steroid therapy for visual loss in patients with giant-cell arteritis. Lancet 2000;355:1572-3.
29. Myles AB, Bacon PA, Daly JR. Single daily dose corticosteroid treatment. Effect on adrenal function and therapeutic efficacy in various diseases. Ann Rheum Dis 1971;30:149-53.
30. Hunder GG, Sheps SG, Allen GL, Joyce JW Daily and alternate-day corticosteroid treatment of giant cell arteritis. Ann Intern Med 1975;82:613-8.